Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung: a Prospective Cohort Study

NCT04634630 is registered in ClinicalTrials.gov with Beatrice Aramini as lead sponsor.

NCT NCT04634630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04634630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung: a Prospective Cohort Study
Lead sponsor
Beatrice Aramini
Phase
Observational
Overall status
Completed
Start date
October 17, 2017
Completion date
October 17, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

csc, lung cancer, nonsmall cell, relapse/recurrence